Close Menu

NEW YORK (GenomeWeb) – Hologic today announced an offering of $350 million of senior notes due in 2025. The proceeds are expected to contribute to retirement of remaining convertible notes, the firm said.

The company said that it has also entered into an amended and restated credit agreement consisting of a new, five-year $1.5 billion senior term loan and $1.5 billion revolving credit facility. It noted that it has used the initial proceeds from the credit agreement to pay off its previous senior secured term loan and revolver.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.